Real World Evidence with Office of Medical Policy Director Jacqueline Corrigan-Curay

We talked to Center for Drug Evaluation & Research Office of Medical Policy Director Jacqueline Corrigan-Curay at BIO about FDA’s current work on real world evidence. Corrigan-Curay explained how FDA doesn’t see a contradiction between randomization and RWE and ways to gradually start incorporating real world data in the drug development.